525 related articles for article (PubMed ID: 17109850)
1. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
[TBL] [Abstract][Full Text] [Related]
2. Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties.
Tian JW; Jiang WL; Zhong Y; Meng Q; Gai Y; Zhu HB; Hou J; Xing Y; Li YX
Neuroscience; 2011 Nov; 196():124-30. PubMed ID: 21925241
[TBL] [Abstract][Full Text] [Related]
3. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of PA01, a novel promising triple reuptake inhibitor.
Hou J; Xing Y; Zuo D; Wu Y; Tian J; Meng Q; Yang M
Physiol Behav; 2015 Jan; 138():141-9. PubMed ID: 25447484
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.
Shao L; Wang F; Malcolm SC; Ma J; Hewitt MC; Campbell UC; Bush LR; Spicer NA; Engel SR; Saraswat LD; Hardy LW; Koch P; Schreiber R; Spear KL; Varney MA
Bioorg Med Chem; 2011 Jan; 19(1):663-76. PubMed ID: 21093273
[TBL] [Abstract][Full Text] [Related]
6. The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor.
Jin ZL; Gao N; Li XR; Tang Y; Xiong J; Chen HX; Xue R; Li YF
Eur Neuropsychopharmacol; 2015 Apr; 25(4):544-56. PubMed ID: 25638027
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis and antidepressant activities of aryl alkanol piperidine derivatives].
Zheng YY; Gao K; Weng ZJ; Li JQ
Yao Xue Xue Bao; 2010 Mar; 45(3):324-9. PubMed ID: 21351508
[TBL] [Abstract][Full Text] [Related]
8. 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.
Carter DS; Cai HY; Lee EK; Iyer PS; Lucas MC; Roetz R; Schoenfeld RC; Weikert RJ
Bioorg Med Chem Lett; 2010 Jul; 20(13):3941-5. PubMed ID: 20570146
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice.
Dhir A; Malik S; Kessar SV; Singh KN; Kulkarni SK
Eur Neuropsychopharmacol; 2011 Sep; 21(9):705-14. PubMed ID: 21277753
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS).
Liang Y; Shaw AM; Boules M; Briody S; Robinson J; Oliveros A; Blazar E; Williams K; Zhang Y; Carlier PR; Richelson E
J Pharmacol Exp Ther; 2008 Nov; 327(2):573-83. PubMed ID: 18689611
[TBL] [Abstract][Full Text] [Related]
11. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
Dhir A; Kulkarni SK
Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
[TBL] [Abstract][Full Text] [Related]
12. The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.
Caldarone BJ; Paterson NE; Zhou J; Brunner D; Kozikowski AP; Westphal KG; Korte-Bouws GA; Prins J; Korte SM; Olivier B; Ghavami A
J Pharmacol Exp Ther; 2010 Dec; 335(3):762-70. PubMed ID: 20864506
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
[TBL] [Abstract][Full Text] [Related]
14. The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake.
Viana A; do Rego JC; von Poser G; Ferraz A; Heckler AP; Costentin J; Kuze Rates SM
Neuropharmacology; 2005 Dec; 49(7):1042-52. PubMed ID: 16040063
[TBL] [Abstract][Full Text] [Related]
15. Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum.
Calapai G; Crupi A; Firenzuoli F; Inferrera G; Squadrito F; Parisi A; De Sarro G; Caputi A
Pharmacopsychiatry; 2001 Mar; 34(2):45-9. PubMed ID: 11302563
[TBL] [Abstract][Full Text] [Related]
16. Potential antidepressant effects of novel tropane compounds, selective for serotonin or dopamine transporters.
Hemby SE; Lucki I; Gatto G; Singh A; Thornley C; Matasi J; Kong N; Smith JE; Davies HM; Dworkin SI
J Pharmacol Exp Ther; 1997 Aug; 282(2):727-33. PubMed ID: 9262336
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.
Lee KH; Park CE; Min KH; Shin YJ; Chung CM; Kim HH; Yoon HJ; Won-Kim ; Ryu EJ; Shin YJ; Nam HS; Cho JW; Lee HY
Bioorg Med Chem Lett; 2010 Sep; 20(18):5567-71. PubMed ID: 20724153
[TBL] [Abstract][Full Text] [Related]
18. Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.
Shobo M; Kondo Y; Yamada H; Mihara T; Yamamoto N; Katsuoka M; Harada K; Ni K; Matsuoka N
J Pharmacol Exp Ther; 2010 Jun; 333(3):772-81. PubMed ID: 20223878
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effect of hyperfoliatin, a polyisoprenylated phloroglucinol derivative from Hypericum perfoliatum (Clusiaceae) is associated with an inhibition of neuronal monoamines uptake.
do Rego JC; Benkiki N; Chosson E; Kabouche Z; Seguin E; Costentin J
Eur J Pharmacol; 2007 Aug; 569(3):197-203. PubMed ID: 17574234
[TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor.
Aluisio L; Lord B; Barbier AJ; Fraser IC; Wilson SJ; Boggs J; Dvorak LK; Letavic MA; Maryanoff BE; Carruthers NI; Bonaventure P; Lovenberg TW
Eur J Pharmacol; 2008 Jun; 587(1-3):141-6. PubMed ID: 18499098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]